Fresenius Medical Care Launches EUR 1 Billion Share Buyback Program

Fresenius Medical Care ( (FMS) ) has provided an update.

On August 11, 2025, Fresenius Medical Care announced the commencement of a share buyback program, which was initially disclosed on June 17, 2025. The program aims to repurchase up to 29,288,814 shares for a total of EUR 1 billion by August 10, 2027. This initiative is part of a strategic move to optimize capital structure and potentially enhance shareholder value. The buyback will be executed in two tranches, with the first tranche involving up to EUR 600 million worth of shares by April 30, 2026. The repurchased shares are primarily intended to be canceled, reducing the company’s share capital, while a smaller portion may be allocated to incentive-based compensation plans. This move is expected to impact the company’s financial operations and market positioning positively.

The most recent analyst rating on (FMS) stock is a Hold with a $23.00 price target. To see the full list of analyst forecasts on Fresenius Medical Care stock, see the FMS Stock Forecast page.

Spark’s Take on FMS Stock

According to Spark, TipRanks’ AI Analyst, FMS is a Neutral.

Fresenius Medical Care’s overall score reflects strong financial performance and positive earnings call highlights, tempered by bearish technical indicators and moderate valuation metrics. The company’s strategic initiatives and robust cash flow are significant strengths, while technical analysis indicates potential short-term challenges.

To see Spark’s full report on FMS stock, click here.

More about Fresenius Medical Care

Fresenius Medical Care is a leading company in the healthcare industry, primarily focusing on providing dialysis services and products. The company is known for its comprehensive care for individuals with chronic kidney failure and operates globally, serving a significant portion of the dialysis market.

Average Trading Volume: 393,164

Technical Sentiment Signal: Hold

Current Market Cap: $14.08B

Find detailed analytics on FMS stock on TipRanks’ Stock Analysis page.